Searched for
RAW MATERIAL PRICES IN PHARMACEUTICALS
World MSME Day: Chemical industry seeks policy support to boost competitiveness amid global trade disruptionsIndian chemical industry leaders are urging a policy overhaul to boost competitiveness ahead of World MSME Day 2026. They highlight the nee...- World MSME Day: Global uncertainty offers Indian MSMEs an opportunity to move up the textile value chain, say expertsAs the second-largest employment generator in the country, the textile sector’s contribution to the economy is crucial, with MSMEs forming ...
- World MSME Day: Gem & jewellery sector calls for MSME-led innovations amid global uncertaintyDespite challenges like fluctuating gold prices and evolving consumer tastes, experts highlight opportunities in design-led, innovative pra...
- Cotton duty or competitiveness? The bigger challenge facing India’s $190 billion textile industryThe government’s temporary import duty relief may ease pressure on mills and exporters, but industry experts say deeper problems in product...
- World MSME Day: Global trade risks weigh on MSMEs; industry seeks competitiveness-focused reformsIndian MSMEs are urging a policy overhaul to boost global competitiveness, citing challenges from geopolitical shifts and supply chain disr...
- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- Kazakh President pitches for Middle Corridor to boost trade with EuropeKazakh President Tokayev's Brussels visit underscored the vital role of the Middle Corridor, a key Asia-Europe trade route, aligning with t...
- Broader market winners! How investors found 15 multibaggers in a muted Nifty year?Despite a subdued Nifty, several Indian stocks have surged, becoming multibaggers for investors. This outperformance is attributed to resil...
- Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Drugmakers yet to see gains from government's minimum import price policyGovernment's Minimum Import Price (MIP) initiative to boost domestic drug makers faces a slow start. Despite setting price thresholds for k...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Nearly 12 ships carrying fertiliser cross Strait of HormuzAt the onset of the Iran war, eight urea, four diammonium phosphate (DAP), one ammonia and three sulphur vessels bound for India were stran...
- India weighs extending 40-product import duty exemption beyond June 30 amid West Asia tensionsThe government will decide on extending import duty exemptions for 40 products after June 30. This decision hinges on the evolving situatio...
- West Asia crisis eases, but peace could elude consumers for nowConsumers in India will not experience immediate price drops for daily essentials and home appliances. Manufacturers are holding onto raw m...
- API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...
- Iran truce may revive India's textile exports, industry saysIndia's textile exports are set for a significant boost following the end of the Iran war. Manufacturers anticipate lower raw material cost...
- India raises price cap on cancer drugs to tackle shortageIndia's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...
- Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
Load More
